Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma

Strahlentherapie und Onkologie

Volumn 187, Issue 5, 2011, Pages 292-299

  Kuhnt, Thomas ^a   Klockenbrink, Ulf ^a   Knipping, Stephan ^b   Lautermann, Juergen ^c   Kriese, Karen ^d   Wienke, Andreas ^d   Hildebrandt, Guido ^a   Hauptmann, Steffen ^d  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

^c Hospital Martha Maria   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Distant metastases; Extracapsular nodal spread; Locally advanced SCCHN; Outcome; Radiochemotherapy; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; LOW DRUG DOSE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; SINGLE DRUG DOSE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 79960309377     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2186-x     Document Type: Article

References (22)

1. Bachaud JM, David JM, Boussin G et al. Combined postoperative radio- therapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 1991;20:243-46.
2. Bernier J, Cooper JS, Pajak TF et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005;27:843-50. (Pubitemid 41395696)
3. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52. (Pubitemid 38580197)
4. Carvalho AL, Nishimoto IN, Califano JA et al. Trends in incidence and prog- nosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-16. (Pubitemid 40344442)
5. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
6. Cooper JS, Pajak TF, Forastiere AA et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck 1998;20:588-94. (Pubitemid 28405799)
7. De Carvalho MB. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 1998;20:16-21. (Pubitemid 27528297)
8. Devinemi VR, Simpson JR, Sessions D et al. Supraglottic carcinoma: impact of radiation therapy on outcome of patients with positive margins and extracapsular nodal disease. Laryngoscope 1991;101:767-70.
9. Fietkau R, Lautenschläger C, Sauer R et al. Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96-3. J Clin Oncol 2006;24:5507.
10. Forastiere AA, Koch W, Trotti A et al. Head and neck cancer. N Engl J Med 2001;345:1890-1900. (Pubitemid 33716564)
11. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20. (Pubitemid 30365531)
12. Hermanek P, Hutter RVP, Sobin LH et al. TNM atlas: illustrated guide to the TNM/pTNM-classification of malignant tumours, 4th ed. Springer Verlag, Berlin, 1998.
13. Hinerman RW, Mendenhall WM, Morris CG et al. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004;26:984-94. (Pubitemid 39488127)
14. Hirabayashi H, Koshii K, Uno A et al. Extracapsular spread of squamous cell carcinoma in neck lymph nodes: prognostic factor of laryngeal cancer. Laryngoscope 1991;101:502-6.
15. Huang DT, Johnson CR, Schmidt-Ullrich R et al. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys 1992;23:737-42.
16. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-81.
17. Kuhnt T, Janich M, Götz U et al. Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands. Strahlenther Onkol 2006;182:325-30. (Pubitemid 43727350)
18. Laramore GE, Scott CB, Al-Sarraf M et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:706-13.
19. Rades D, Stoehr M, Meyners T et al. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Strahlenther Onkol 2008;184:198-205. (Pubitemid 351508132)
20. Steinmann D, Cerny B, Karstens JH et al. Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis. Strahlenther Onkol 2009;185:682-8.
21. Studer G, Seifert B, Glanzmann C. Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pretreatment staging? Strahlenther Onkol 2008;184:580-5.
22. Tribius S, Kronemann S, Kilic Y et al. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:675-81.